Article Details

AEON Biopharma Doses First Patient in Phase 2 Trial of ABP-450 for the Treatment of Cervical ...

Retrieved on: 2021-04-05 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

AEON Biopharma Doses First Patient in Phase 2 Trial of ABP-450 for the Treatment of Cervical .... View article details on hiswai:

Excerpt

NEWPORT BEACH, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc., a private clinical-stage biopharmaceutical company focused ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up